Physician
Civic Center Pediatrics
Civic Center Pediatrics was paid $4.32M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoCIVIC CENTER PEDIATRICS
NORTH LAS VEGAS, NV 89030
NORTH LAS VEGAS, NV 89030
33aNPI1275716086assigned 12/14/2007
33bProvider typePediatrics Physician
28Total paid$4.32M
24GClaims153,877
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#12 of 267
Median peer was paid$116K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,650 | $148K | |
| 2019 | 31,682 | $740K | |
| 2020 | 19,102 | $478K | |
| 2021 | 29,520 | $655K | |
| 2022 | 27,827 | $787K | |
| 2023 | 22,259 | $825K | |
| 2024incomplete | 17,837 | $687K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 28,343 | 23,873 | $1.60M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 15,890 | 13,769 | $576K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.5% | 5,494 | 4,898 | $411K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.1% | 4,645 | 4,190 | $352K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.5% | 3,978 | 3,541 | $324K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.5% | 4,958 | 4,095 | $322K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.4% | 3,792 | 3,280 | $189K |
| 90461 | 3.4% | 4,679 | 3,687 | $148K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 4,469 | 3,544 | $79K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 1.3% | 3,532 | 3,044 | $55K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,258 | 1,181 | $37K |
| 94760 | <1% | 16,438 | 14,218 | $26K |
47 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 323 | $24K |
| 99381 | <1% | 361 | $23K | |
| 96127 | <1% | 5,587 | $20K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 504 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 383 | $15K |
| 99188 | <1% | 1,297 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,014 | $13K |
| 94010 | <1% | 397 | $10K | |
| 95117 | <1% | 1,334 | $8K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,429 | $8K |
| 99383 | <1% | 93 | $7K | |
| 92551 | <1% | 765 | $6K | |
| 99070 | <1% | 1,144 | $6K | |
| 90651 | <1% | 1,626 | $6K | |
| 36416 | <1% | 3,638 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 492 | $5K |
| 99384 | <1% | 18 | $2K | |
| 81003 | <1% | 2,457 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 14 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 51 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 47 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 188 | $950.13 |
| 99382 | <1% | 12 | $930.32 | |
| 96161 | <1% | 312 | $788.42 | |
| 90621 | <1% | 572 | $731.74 | |
| 94664 | <1% | 61 | $717.02 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $307.89 |
| 90677 | <1% | 584 | $264.13 | |
| 90670 | <1% | 3,699 | $241.38 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 24 | $226.13 |
| 90698 | <1% | 2,856 | $137.11 | |
| 90686 | <1% | 4,230 | $45.45 | |
| 90633 | <1% | 1,935 | $23.82 | |
| 99173 | <1% | 4,292 | $2.47 | |
| 90697 | 0% | 1,015 | $0.00 | |
| 90680 | 0% | 2,465 | $0.00 | |
| 90619 | 0% | 332 | $0.00 | |
| 90744 | 0% | 1,342 | $0.00 | |
| 99000 | 0% | 4,383 | $0.00 | |
| 90696 | 0% | 384 | $0.00 | |
| 90710 | 0% | 1,831 | $0.00 | |
| 90734 | 0% | 1,098 | $0.00 | |
| 90685 | 0% | 358 | $0.00 | |
| 90715 | 0% | 394 | $0.00 | |
| 99072 | 0% | 19 | $0.00 | |
| 90380 | 0% | 15 | $0.00 | |
| 90681 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRANASINGHE, RUCHIKA (PRESIDENT)